Moon Surgical Secures FDA Clearance for ScoPilot, First AI-Powered Intraoperative Tool

Moon Surgical, a French-American pioneer in surgical innovation, announced the United States Food and Drug Administration (FDA) clearance for ScoPilot. Ena...

March 20, 2025 | Thursday | News
Signal12 Secures FDA Alignment for Phase 3 Trial of Pro-ocular™ in Ocular Graft-versus-Host Disease

 Signal12, Inc., a clinical-stage ophthalmic pharmaceutical company focused on first-of-a-kind patented technologies that enable existing drugs to act...

March 19, 2025 | Wednesday | News
Whitehawk Therapeutics Debuts New Identity, Advances ADC Portfolio

Whitehawk Therapeutics, Inc. formerly known as Aadi Bioscience, Inc., an oncology therapeutics company applying advanced technologies to establis...

March 19, 2025 | Wednesday | News
Mozart Therapeutics Completes Successful Phase 1a Study of MTX-101 in Healthy Adults

 Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, announce the successful completion of thei...

March 19, 2025 | Wednesday | News
Telix Pharmaceuticals' Illuccix® Receives Full ANVISA Approval for Prostate Cancer Imaging in Brazil

Telix Pharmaceuticals Limited announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approve...

March 19, 2025 | Wednesday | News
New Diagnostics for Schistosomiasis Receive JPY 780 Million Investment to Improve Global Health

Schistosomiasis is one of 21 NTDs that affects approximately 250 million people worldwide, with 90% of cases occurring in Africa. People become infect...

March 19, 2025 | Wednesday | News
HistoIndex Launches FibroSIGHT to Improve Fibrosis Assessment in MASH Patients

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory De...

March 19, 2025 | Wednesday | News
Life Molecular Imaging & St. Teresa’s Hospital Launch Neuraceq® in Hong Kong for Early Alzheimer’s Diagnosis

Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be av...

March 18, 2025 | Tuesday | News
Dyne’s DYNE-251 Shows Sustained Functional Gains in DELIVER Trial for DMD

Dyne Therapeutics, Inc., a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscul...

March 18, 2025 | Tuesday | News
Amgen’s UPLIZNA® Shows Lasting Efficacy in Phase 3 MINT Trial

Amgen announced new data from the Phase 3, registrational MINT trial evaluating the efficacy and safety of UPLIZNA® (inebilizumab-cdon) in adults ...

March 18, 2025 | Tuesday | News
AbbVie’s ELAHERE® Shows Major Survival Gains in Final Phase 3 MIRASOL Data

AbbVie  announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab s...

March 18, 2025 | Tuesday | News
AbbVie’s Final Phase 3 MIRASOL Data Confirms 32% Reduced Risk of Death with ELAHERE in Platinum-Resistant Ovarian Cancer

Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with E...

March 17, 2025 | Monday | News
Laplace Interventional Secures Series C Financing to Advance Transcatheter Tricuspid Valve Technology

The Series C financing was led by a global strategic investor along with participation from new investors Aphelion Cardeation and Unorthodox Ventures. Ex...

March 17, 2025 | Monday | News
Dr. Reddy’s Recalls Levetiracetam Injection in the U.S. Due to Mislabeled Infusion Bags

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “D...

March 14, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close